MS service variance – the way forward

15 October, 2018 | Posted in:

Access to services for people with multiple sclerosis (MS) is well known to be varied, with phrases like ‘postcode lottery’ and ‘patchy’ commonly used to describe people’s access to the care and support that they need. Anecdotally known of for some time, recent evidence now highlights not just the variation, but the impact it has […]

Continue Reading »

MS community fight for new drug to treat primary-progressive MS

14 September, 2018 | Posted in:

New disease-modifying drug Ocrelizumab could be the treatment that many people with primary-progressive MS have been waiting for, but despite positive clinical outcomes, it has yet to be licensed here in the UK. Multiple sclerosis (MS) causes inflammation of the nerve cells in the brain and spine, and disease-modifying therapies (DMTs) are a form of […]

Continue Reading »

Autumn 2018 MS MasterClass project winners announced

7 September, 2018 | Posted in:

Congratulations are thoroughly deserved by our latest MS MasterClass project winners. The most recent cohort of delegates to complete their intermodule projects met last night at their Awards dinner during this Autumn MasterClass course. MS specialist nurse Daisy Cam won the Project Award for her research into the use of alternative therapies in treating MS. […]

Continue Reading »

Technology advances in neurology healthcare

31 August, 2018 | Posted in:

We live in a technological era and seldom a moment goes by when we are not using some sort of device or app, browsing the internet or relating across social media. Healthcare has long seemed behind in using these advances in technology to improve their services, but this is beginning to change. Exciting headway From […]

Continue Reading »

Changes to diagnostic criteria in MS to improve speed and accuracy of diagnosis

20 July, 2018 | Posted in:

Experts in multiple sclerosis (MS) have recently recommended changes to the widely used diagnostic criteria for the condition. The McDonald criteria, first published in 2010, allows diagnosis of MS after one relapse, if an MRI imaging scan shows evidence of damage to the brain through lesions developing. Lately experts have gathered to review the criteria, […]

Continue Reading »

2018 MS MasterClass 3 winners announced

8 June, 2018 | Posted in:

Last night, the winners of the 2018 MS MasterClass intermodule delegate projects were announced. Dr Rachel Dorsey-Campbell was voted winner by her peer group and faculty for implementing a pharmacy-led prescribing and monitoring service for natalizumab. Her research found that the new service resulted in better monitoring of patient health when being treated, making the […]

Continue Reading »

GIRFT (Get it Right First Time) – Parkinson’s and MS services to be reviewed in National Census

31 May, 2018 | Posted in:

Following the successful completion of a quality improvement pilot in orthopaedic surgery entitled Getting It Right First Time (GIRFT), the Department of Health and NHS Improvement (NHSI) have commissioned an expansion of the GIRFT programme that will cover an additional 35 clinical areas over four years from April 2017 to support providers in delivering clinical […]

Continue Reading »